Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
The Schall Law Firm Starts Inquiry Into Accusations Against Marinus Pharmaceuticals Inc And Invites Impacted Investors To Communicate
11:00am, Saturday, 29'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceu
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securit
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securit
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmace
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securit
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) between March 17,
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securit
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceu
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceu
Marinus Pharmaceuticals Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
09:00am, Friday, 28'th Jun 2024
Investors can contact the law firm at no cost to learn more about recovering their losses
NEW YORK , June 28, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS). Shareholders who purchased shares of MRNS duri
Contact Levi & Korsinsky by August 5, 2024 Deadline to Join Class Action Against Marinus Pharmaceuticals, Inc.(MRNS)
08:10pm, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securit
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit – MRNS
08:10pm, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securit
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit
07:49pm, Thursday, 27'th Jun 2024
Shareholders with losses of $100,000 or more are encouraged to contact the firm. BENSALEM, Pa.
Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNS
04:40pm, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securit
